HopeStage
Back to all studies
RecruitingNCT05917119

Bright-light therapy or sham for daytime symptoms of sleep apnea

About this titleRead the official source — NCT05917119
Interventional studyAges 40–65United StatesDepression
The study in practice

Understand this study

Who could participate?

Listed age limits: 40 years to 65 years.

Listed locations
PittsburghSee all locations and recruitment

Get this study by email

HopeStage may email me about this study.
Loading the security check...

What to know before participating

A point to clarify

This summary does not cover all risks or eligibility requirements. What risks or changes to my care would apply to me?

Study clarity

Things to check before joining

Study start dateStarted: October 26, 2024
Recruitment status
Recruiting
Enrollment listed in the registry
60
Sponsor
VA Office of Research and Development
Sponsor type
Government agency
Study type
Other
Intervention type
OTHER
Study phase
Not clearly listed
Locations
United States
Age range
From 40 Years to 65 Years
Official registry ID
NCT05917119
Official title
Show the full official title

Bright Light Therapy for Residual Daytime Symptoms Associated With Obstructive Sleep Apnea

Recruitment & locations

Currently recruiting

Pittsburgh

FAQ

Questions about this study

Who is behind this study?

The study sponsor is VA Office of Research and Development, a government agency.

Who can participate?

Listed age limits: 40 years to 65 years.

Is this study still recruiting?

The registry lists this study as recruiting.

Want to explore more studies?

Explore studies